Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Change in Accured Expenses (2023 - 2025)

Historic Change in Accured Expenses for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to $8.6 million.

  • Nuvation Bio's Change in Accured Expenses rose 14295.02% to $8.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.1 million, marking a year-over-year increase of 37719.44%. This contributed to the annual value of $6.8 million for FY2024, which is 2983043.48% up from last year.
  • Per Nuvation Bio's latest filing, its Change in Accured Expenses stood at $8.6 million for Q3 2025, which was up 14295.02% from $106000.0 recorded in Q2 2025.
  • Nuvation Bio's Change in Accured Expenses' 5-year high stood at $8.6 million during Q3 2025, with a 5-year trough of -$8.9 million in Q1 2025.
  • For the 3-year period, Nuvation Bio's Change in Accured Expenses averaged around $596454.5, with its median value being $1.2 million (2023).
  • Per our database at Business Quant, Nuvation Bio's Change in Accured Expenses soared by 45538.31% in 2024 and then plummeted by 69211.92% in 2025.
  • Nuvation Bio's Change in Accured Expenses (Quarter) stood at -$2.1 million in 2023, then soared by 455.38% to $7.3 million in 2024, then increased by 17.1% to $8.6 million in 2025.
  • Its Change in Accured Expenses stands at $8.6 million for Q3 2025, versus $106000.0 for Q2 2025 and -$8.9 million for Q1 2025.